Stay updated on Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Sign up to get notified when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.

Latest updates to the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study Locations section has been expanded to list multiple sites across the US, Canada, Europe, Australia, and Asia, giving potential participants clearer access to participating centers. This improves visibility of where the study is conducted and helps users identify nearby sites.SummaryDifference3%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedNew text states that publications are provided voluntarily by the person entering study information and that some publications are automatically filled from PubMed. The revision version is updated to v3.3.2.SummaryDifference0.3%

- Check44 days agoChange DetectedThe government funding/operating status notice was removed from the page. Core study details and links remain unchanged.SummaryDifference0.1%

- Check58 days agoChange DetectedThe Study Details page appears unchanged between the screenshots; there are no new locations, eligibility criteria, or outcomes visible. The differences seem limited to minor UI elements.SummaryDifference0.2%

- Check87 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check94 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

Stay in the know with updates to Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.